Tenaya

Marea Therapeutics

This biotechnology company develops medicines for cardiometabolic and cardioendocrine diseases using human genetic data for patients with unmet medical needs.

PacingCure

This biotechnology company develops precision gene therapies and biological pacemakers for patients suffering from cardiac rhythm disorders and heart failure.

Phlox Therapeutics

This company develops RNA-based gene therapies to treat patients with rare genetic heart diseases, including cardiomyopathies and laminopathies.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Verve Therapeutics

The company develops gene-editing medicines to treat patients with cardiovascular diseases and genetic disorders like familial hypercholesterolemia.

Rocket Pharma

This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.

Kardigan

This company develops precision cardiovascular medicines and a clinical intelligence platform for patients with heart diseases such as dilated cardiomyopathy and hypertension.

RyCarma

This biotechnology company develops small molecule therapeutics for patients with cardiovascular and skeletal muscle diseases, specifically heart failure and rare genetic myopathies.